Long-term Results of the Stapled Transanal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Aug 31, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the long-term results of a surgical procedure called the Stapled Transanal Rectal Resection (STARR) for treating a condition known as rectocele, which affects many women and can impact their quality of life. The goal of the trial is to gather more information about how well this surgery works over a longer period of time, as most previous studies only looked at short-term results. The investigators want to see if the STARR technique is effective and if it aligns with recommendations from health experts.
To participate in this trial, women aged 18 and older who have undergone surgery for rectocele at least 10 years ago may be eligible. Participants will be informed about the study and will need to agree to take part. Those who choose to join can expect to share their experiences and outcomes from the surgery, which will help improve understanding of the procedure's effectiveness. Importantly, the trial is currently recruiting participants, and those interested should speak with their healthcare provider for more information.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient operated for rectocele for 10 or more
- • Age 18 and over
- • Informed patients
- Exclusion Criteria:
- • Patient objection
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grenoble, , France
Patients applied
Trial Officials
Jean-Luc Faucheron, MD
Principal Investigator
CHU Grenoble Alpes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials